Two left in running for Healthscope hospital properties

MELBOURNE: The sale of a $1.2bn portfolio of Healthscope hospital properties is understood ... read more
Neuren drug finally been cleared by FDA in USA

SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from ... read more